DrugMonitor™ Anti-Citatuzumab Bogatox Antibody (VS-1224-YC283)
CAT#: VS-1224-YC283
VB6-845 is a humanized antibody fragment targeting EpCAM and fused with a deimmunized form of the cytotoxin Bouganin, developed for systemic use against metastatic cancer, showing effective pre-clinical cancer cell-killing properties. The DrugMonitor™ Anti-Citatuzumab Bogatox Antibody (VS-1224-YC283) is an anti-drug antibody (ADA) against Citatuzumab Bogatox. This drug-based antibody is raised in mice immunized with the Citatuzumab Bogatox. The anti-Citatuzumab Bogatox antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Citatuzumab Bogatox in samples.
Specifications
- Host Animal
- Mouse
- Specificity
- Citatuzumab Bogatox
- Target
- Citatuzumab Bogatox
- Immunogen
- Citatuzumab Bogatox
- Type
- Mouse IgG
- Species Reactivity
- Human
- Purity
- >95%
- Purification
- Protein G
- Applications
- ELISA, PK/PD, ADA control
- Format
- Liquid
- Concentration
- Batch-dependent
- Buffer
- PBS, pH 7.4
- Preservative
- No preservatives
- Storage
- Store at 4°C for 1-2 weeks and at -20°C for 1 year. Avoid repeated freezing and thawing.
- Generic name
- Citatuzumab Bogatox
REVIEWS AND Q&AS
CITATIONS
RESOURCES
DOWNLOADS
RELATED PRODUCTS
Inquiry
Navs
Customer Review
There are currently no Customer reviews or questions for VS-1224-YC283. Click the button above to contact us or submit your feedback about this product.
Submit Your Publication
Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.
Downloadable Resources
Download resources about recombinant antibody development and antibody engineering to boost your research.
Datasheet
MSDS
COA
Certificate of Analysis LookupTo download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number:
See other products for "Citatuzumab bogatox"
Anti-Human EpCAM Recombinant Antibody Fab Fragment, 17-1A (Citatuzumab Bogatox)Recombinant antibody Fab to EpCAM. Citatuzumab bogatox (VB6-845) is a monoclonal antibody Fab fragment fused with bouganin, an ribosome inactivating protein from the plant Bougainvillea spectabilis. It has undergone pre-clinical trials for the treatment of ovarian cancer and other solid tumors.
Specific Inquiry
Add to compare
See Our Custom Production in Action
Popular Products
Application: FC, IP, ELISA, Neut, FuncS, IF, ICC
Application: WB, FuncS, IF, Neut, ELISA, FC, IP
Application: IF, IP, Neut, FuncS, ELISA, FC, ICC
Application: FC, IB, Block, Inhib, FuncS, ELISA, FACS, IP, IF
Application: SPR, Inhib, FuncS
Application: ELISA, IHC, FC, IP, IF, FuncS
Application: FC, IA, IF, IP, IHC, FuncS
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
